A national survey conducted by the National Foundation for Infectious Diseases (NFID) has found that 77% of American adults support vaccines, yet widespread uncertainty persists about which vaccines are needed. The survey, which focused on respiratory vaccines including flu, RSV, pneumococcal disease, and Covid-19, highlights a troubling gap between positive attitudes and actual vaccination behavior.
According to the results, while more than three-quarters of adults view vaccines favorably, only 48% reported getting vaccinated for at least one of these four vaccine-preventable illnesses in the past year. This low uptake means many Americans are missing out on the benefits of vaccination, including protection against severe illness, reduced hospitalizations, and lower risk of complications. The implications are significant: without clearer guidance, the country risks unnecessary suffering and economic costs from preventable diseases.
Speaking during the release of the survey findings, NFID Medical Director Robert Hopkins, Jr. emphasized the lost opportunity to protect families and loved ones when fewer people get vaccinated regularly. The survey suggests that healthcare professionals are well positioned to bridge this gap: about 60% of respondents said they trust or have a lot of trust in healthcare professionals regarding their health. This trust presents an opportunity for the medical community to provide consistent, clear vaccine recommendations so that people know which vaccines they need and when.
Accessibility also emerged as a barrier. 22% of participants reported encountering challenges when seeking respiratory vaccines, such as the vaccine being unavailable or long wait times at medical facilities. Addressing these access issues is crucial, as removing barriers can lead to higher vaccination rates and measurable public health benefits, including reducing the economic toll of infectious diseases.
Parallel efforts by companies like Co-Diagnostics Inc. (NASDAQ: CODX) to develop accessible and affordable testing kits for home and non-hospital settings could complement vaccination efforts by enabling early diagnosis and preventing diseases from progressing to life-threatening levels. Such innovations are part of a broader push to improve public health infrastructure.
As the nation grapples with respiratory disease seasons, the survey underscores the need for coordinated action to turn positive vaccine sentiment into actual vaccination. By providing clarity and improving access, policymakers and healthcare providers can help ensure that the 77% who support vaccines actually get them, ultimately saving lives and reducing the burden on the healthcare system.
